Chancroid and human immunodeficiency virus infection - A review

International Journal of Dermatology

Volumn 47, Issue 1, 2008, Pages 1-8

  Mohammed, Tahir T ^a   Olumide, Yetunde Mercy ^a,b  

^a Department of Medical Microbiology and Parasitology   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANALGESIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; CIPROFLOXACIN; COCAINE; ERYTHROMYCIN; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOLISM; CLINICAL FEATURE; COCAINE DEPENDENCE; DRUG COST; DRUG TREATMENT FAILURE; ENZYME IMMUNOASSAY; GENITAL ULCER; HAEMOPHILUS DUCREYI; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION SENSITIVITY; LYMPHADENITIS; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PROSTITUTION; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; ULCUS MOLLE; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; CHANCROID; DISEASE SUSCEPTIBILITY; FEMALE; HAEMOPHILUS DUCREYI; HIV; HIV INFECTIONS; HUMANS; LYMPHADENITIS; MALE; SEXUALLY TRANSMITTED DISEASES;

EID: 37449005339     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03435.x     Document Type: Review

References (59)

1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
2. Mertens TE, Hayes RJ, Smith PG. Epidemiological methods to study the interaction of HIV infection and other sexually transmitted diseases. AIDS 1990; 4: 57-65.
3. Cohen MS. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet 1998; 351 (Suppl. iii): 5-7.
4. MacDonald KC, Cameron DW, D'Costa LJ, et al. Evaluation of fleroxacin (RO23-6240) as single oral dose therapy of culture proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989; 33: 612-614.
5. Plourde PJ, D'Costa LJ, Agoki E, et al. A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 1992; 165: 949-952.
6. Bogaerts J, Kestens L, Tello WM, et al. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: In vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole. Clin Infect Dis 1995; 20: 924-930.
7. Tyndall M, Malisa M, Plummer FA, et al. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 1993; 167: 469-471.
8. Joint United Nations Programme on HIV/AIDS (UNAIDS). Sexually Transmitted Disease: Policies and Principles for Prevention and Care. New York: WHO, 1997: 6.
9. Risbud A, Chan-Tack K, Gadkari D, et al. The aetiology of genital ulcer disease by multiple polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis 1999; 26: 55-62.
10. Behets FMT, Braithwaite AR, Hylton-Kong T, et al. Genital ulcers: aetiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. Clin Infect Dis 1999; 28: 1086-1090.
11. Chen CY, Ballard RC, Beck-sague CM, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: The herpetic infection. Sex Transm Dis 2000; 27: 21-29.
12. Steen R. Eradicating Chancroid. Bull World Health Org 2001; 79: 818-826.
13. Schimid TP, Saunders LL Jr, Blount JH, et al. Chancroid in the United States. Re-establishment of an old disease. J Am Med Assoc 1987; 258: 3265.
14. Shulte JM, Martrich FM, Schmid GP, et al. Chancroid in the United States. 1981-1990 evidence for underreporting of cases. MMWR 1992; 41 (SS-3): 57-61.
15. Morse SA. Chancroid detected by polymerase chain reaction: Jackson, Mississippi 1994. MMWR 1995; 44: 567-574.
16. Dicarlo RP, Armentar BS, Martin DH, et al. Chancroid epidemiology in New Orleans men. J Infect Dis 1995; 172: 446-452.
17. D'Costa LJ, Plummer FA, Bowmer I, et al. Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis 1985; 12: 64.
18. Chirgwin K, DeHovitz JA, Dillon S, et al. HIV infection, genital ulcer disease and crack cocaine use among patients attending a clinic for sexually transmitted disease. Am J Public Health 1991; 81: 1576-1579.
19. Dada AJ, Ajayi AO, Diamond-stone L, et al. A serosurvey of Haemophilus ducreyi, syphilis and herpes simplex virus type 2 and their association with HIV female sex workers in Lagos, Nigeria. Sex Transm Dis 1998: 25: 237-242.
20. Brunham RC, Ronald AR. Epidemiology of sexually transmitted disease in developing countries. In: Wasserheif J, Aral S, Holmes KK, eds. Research Issues in Human Behaviour, STD in the AIDS Era. Washington DC: American Society of Microbiology, 1991: 61-80.
21. Hawkes S, West B, Wilson S, et al. Asymptomatic carriage of H. ducreyi, confirmed by the polymerase chain reaction. Genitourin Med 1995; 71: 224-227.
22. Plummer F, D'Costa L, Nsanze H, et al. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet 1983; 2: 1293-1295.
23. Ronald AR, Abritton W. Chancroid and Haemophilus ducreyi. In: Holmes K, Sparling P, Mardh P, et al., eds. Sexually Transmitted Diseases, 3rd edn. New York: McGraw-Hill, 1999: 515-523.
24. Spinola SM, Wild LM, Apicella MA, et al. Experimental human infection with Haemophilus ducreyi. J Infect Dis 1994; 169: 1146-1150.
25. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implication for control. Med Clin North Am 1990; 74: 1339-1352.
26. Sehgal VN, Srivastava G. Chancroid: Contemporary appraisal. Int J Dermatol 2003; 42: 162-190.
27. Abeck D, Korting HC, Zaba R, et al. Soluble interleukin-2 receptors in urine and serum of patients with chancroid and their response to therapy. Int J STD AIDS 1990; 1: 282-284.
28. San Mateo LR, Toffer KL, Kawule TH. The sod A gene of Haemophilus ducreyi encodes a hydrogen peroxide-inhabitable superoxide dismutase. Gene 1998; 207: 251-257.
29. Ward CK, Lumbley SR, Latimer JL, et al. Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein. J Bacteriol 1998; 180: 6013-6022.
30. Montero JA, Zaulyanov LL, Houston SH, et al. Sexually transmitted disease. Chancroid: An update. Infect Med 2002; 19: 174-178.
31. Al Tawfiq JA, Thornton AC, Katz BP, et al. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 1998; 178: 168-187.
32. Morse SA, Trees DL, Htun Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular biological methods for the diagnosis of genital ulcer disease in Lesotho: Association with human immunodeficiency virus infection. J Infect Dis 1997; 175: 583-589.
33. Olumide YM. A Self-Instructional Textbook of Acquired Immune Deficiency Syndrome. Lagos: Longman, 2002: 45.
34. Orle KA, Gates CA, Martin DH, et al. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and Herpes simplex virus type 1 & 2 from genital ulcers. J Clin Microbiol 1996; 34: 49-54.
35. Totten PN, Kuypers JM, Chen CY, et al. Aetiology of genital ulcer disease in Dakar, Senegal and comparison of PCR serologic assays for detection of Haemophilus ducreyi. J Clin Microbiol 2000; 38: 268-273.
36. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160: 380-384.
37. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted disease and immunosuppression in female sex workers in Abidjan, Cote d'Ivore. AIDS 1997; 11: F85-F93.
38. Fleming DT, Wasserhert JN. From epidemiological synergy to public health policy and practice: The contribution of sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
39. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type I (HIV I) RNA concentration with genital ulcer disease in HIV infected men in Malawi. J Infect Dis 1998; 177: 224-227.
40. Van Laer L, Vingerhoets J, Vamham G, et al. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV-negative and HIV-positive chancroid patients by Haemophilus ducreyi antigen. Clin Exp Immunol 1995: 102: 234-50.
41. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of HIV-1: Risk factors for seroconversion in men. Lancet 1989; 2: 403-407.
42. Telzak EE, Chiasson MA, Bevier PJ, et al. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993; 119: 1181-1186.
43. King R, Choudhri SN, Nasio J, et al. Clinical and in-situ cellular responses to H. ducreyi in the presence or absence of HIV infection. Int J STD 1998; 9: 531-536.
44. Plummer FA, Wainberg MA, Ptourde P, et al. Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudates of HIV infected men by culture and gene amplification. J Infect Dis 1990; 161: 510-511.
45. Sehgal VN, Shyam Prasad AL. Chancroid of chancroidal ulcer. Dermatologica 1985; 170: 136-141.
46. Sehgal VN. Venereal Diseases, 3rd edn. New Delhi: Jaypee Medical Publishers, 1994: 70-74.
47. Jonasson JA. Haemophilus ducreyi. Int J STD AIDS 1993; 4: 317-321.
48. Brown TJ, Yenmoore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 1999; 41: 511-532.
49. Ceberry IP, Djeha D, Kacou DE, et al. Chronic genital ulceration and HIV infection: 29 cases. Med Trop (Mars) 1999; 59: 279-282.
50. Rosen T, Brown TJ. Cutaneous manifestation of sexually transmitted disease. Med Clin North Am 1998; 82: 1081-1104.
51. WHO. Management of Patients with Sexually Transmitted Disease. WHO Technical Report Series no. 810. Geneva: World Health Organization (WHO), 1991.
52. Nigeria: Syndromic Management of Sexually Transmitted Infections. A Manual for Health Workers. Abuja: Fed Min of Health, 2001.
53. Htun Y, Morse SA, Dangor Y et al. Comparison of clinically directed, disease specific, and syndromic protocols for the management of genital ulcer disease in Lesotho. Sex Transm Infect 1998; 74 (Suppl. 1): S23-s28.
54. Schmid GP. Treatment of chancroid. Clin Infect Dis 1999/1997; 28: S14-S20.
55. Tyndall MW, Plourde PJ, Agoki E et al. Fleroxacin in the treatment of chancroid - an open study in men seropositive and seronegative for HIV-1. Am J Med 1993; 94: 855-885.
56. Plummer FA, Maggwan X, D'Costa LJ, et al. Cefotaxime treatment of H. ducreyi infection in Kenya. Sex Transm Dis 1984; 11: 304-307.
57. Rutanarugsa A, Vorachit M, Polnicom N, et al. Drug resistance to Haemophilus ducreyi. South East Asian J Trop Med Public Health 1990; 21: 185-193.
58. Ison CA, Dillon JR, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998; 351 (Suppl. 111): 8-11.
59. MaeDonald KS, Cameron DW, D'Costa J, et al. Evaluation of fleroxacin (RO 23-6240) as single dose therapy for culture proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989; 33: 612-614.